First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort
- DOI
- 10.1007/s12672-026-04853-0
- Published
- 2026-03-21
- Container
- Discover Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12672-026-04853-0,
title = {First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort},
author = {Xiaoting Ma and Kai Ou and Wenwei Yang and Biyang Cao and Jie Chen and Qi Wang and Lizhen Gao and Lin Yang},
year = {2026},
journal = {Discover Oncology},
doi = {10.1007/s12672-026-04853-0},
url = {https://doi.org/10.1007/s12672-026-04853-0}
}RIS
TY - JOUR TI - First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort AU - Xiaoting Ma AU - Kai Ou AU - Wenwei Yang AU - Biyang Cao AU - Jie Chen AU - Qi Wang AU - Lizhen Gao AU - Lin Yang PY - 2026 JO - Discover Oncology DO - 10.1007/s12672-026-04853-0 UR - https://doi.org/10.1007/s12672-026-04853-0 ER -
APA
Ma, X., Ou, K., Yang, W., Cao, B., Chen, J., Wang, Q., Gao, L., & Yang, L. (2026). First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort. Discover Oncology. https://doi.org/10.1007/s12672-026-04853-0
Source records
- crossref · retrieved 2026-09-27T16:06:47.046Z